Drug Profile
Anthrax vaccine adjuvant - RxKinetix
Alternative Names: ProJuvant™Latest Information Update: 22 Feb 2008
Price :
$50
*
At a glance
- Originator RxKinetix
- Class Vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anthrax
Most Recent Events
- 30 Oct 2002 Preclinical trials in Anthrax in USA (Injection)
- 30 Oct 2002 Preclinical trials in Anthrax in USA (Intranasal)